ECG
ECG is an intervention with 76 clinical trials. Currently 12 active trials ongoing. Historical success rate of 81.4%.
Success Metrics
Based on 35 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
8
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
76.1%
35 of 46 finished
23.9%
11 ended early
12
trials recruiting
76
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Differences in ECG- vs. proLonged cardIac MonItor-DeTected Atrial Fibrillation in STROKE Patients (DELIMIT AF-STROKE)
Risk Factors, Etiology and Predictable Outcomes With Risk Stratification Scores in Acute Heart Failure Patients
Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)
Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
Clinical Trials (76)
Differences in ECG- vs. proLonged cardIac MonItor-DeTected Atrial Fibrillation in STROKE Patients (DELIMIT AF-STROKE)
Risk Factors, Etiology and Predictable Outcomes With Risk Stratification Scores in Acute Heart Failure Patients
Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)
Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer
Rising ctDNA to Tailor Endocrine Therapy Switch in Patients With ER+/HER2- Metastatic Breast Cancer.
ALIGN-ACS Pilot Study
The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females
Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis
Long-term Alterations of Host-microbiome Interactions and Cardiovascular and Respiratory Diseases Progression After Pneumonia
Structured Review: To Optimise Management and Prevent Harm in COPD
Better Understanding of Fatigue After STroke
Next Generation Personalized Neuroblastoma Therapy
Diagnosis of Postoperative Atrial Fibrillation by a Smartwatch
Study of Maintenance of the Efficiency and Adverse Effects of Pharmacological Treatments in Sex Offenders With Paraphilia
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors
Ventricular Repolarization in Patients With Premature Ovarian Insufficiency (QTIOP)
Eltanexor (KPT-8602) With Inqovi (Decitabine-Cedazuridine) in High-Risk Myelodysplastic Syndromes
BMS-986253 in Myelodysplastic Syndromes
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 76